These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Failure of naloxone to reduce manic symptoms. Davis GC; Extein I; Reus VI; Hamilton W; Post RM; Goodwin FK; Bunney WE Am J Psychiatry; 1980 Dec; 137(12):1583-5. PubMed ID: 7435717 [TBL] [Abstract][Full Text] [Related]
23. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy. Wilson LG; Roberts RW; Gerber CJ; Johnson MH J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441 [TBL] [Abstract][Full Text] [Related]
24. A study of naloxone with schizophrenic and manic patients. Sethi BB; Prakash R Br J Psychiatry; 1981 Jun; 138():501-3. PubMed ID: 7028200 [TBL] [Abstract][Full Text] [Related]
25. Comparison of pimozide and chlorpromazine in acute schizophrenia. Pecknold JC; McClure DJ; Allan T; Wrzesinski L Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898 [TBL] [Abstract][Full Text] [Related]
26. Failure of progesterone treatment in puerperal mania. Meakin C; Brockington IF Br J Psychiatry; 1990 Jun; 156():910. PubMed ID: 2207533 [No Abstract] [Full Text] [Related]
27. New drugs for mania? von Zerssen D; Emrich HM Br J Psychiatry; 1983 May; 142():532-3. PubMed ID: 6409197 [No Abstract] [Full Text] [Related]
28. Reserpine withdrawal psychosis: the possible role of denervation supersensitivity of receptors. Kent TA; Wilber RD J Nerv Ment Dis; 1982 Aug; 170(8):502-4. PubMed ID: 7097268 [TBL] [Abstract][Full Text] [Related]
29. New possible indications of pimozide. Iruela LM; IbaƱez-Rojo V; Gilaberte I; Oliveros SC J Clin Psychiatry; 1992 May; 53(5):172-3. PubMed ID: 1497742 [No Abstract] [Full Text] [Related]
30. Lithium excretion and therapeutic response in mania. Sampath G; Channabasavanna SM; Rao BS; Subhash MN Indian J Med Res; 1981 May; 73():768-71. PubMed ID: 7262950 [No Abstract] [Full Text] [Related]
32. Lithium and mania. Tosteson DC Sci Am; 1981 Apr; 244(4):164-6, 168, 171-2 et passim. PubMed ID: 6261327 [No Abstract] [Full Text] [Related]
33. Rapid recurrence of mania following lithium withdrawal. Lapierre YD; Gagnon A; Kokkinidis L Biol Psychiatry; 1980 Dec; 15(6):859-64. PubMed ID: 7459406 [No Abstract] [Full Text] [Related]
34. Lithium and the changing incidence of mania. Symonds RL; Williams P Psychol Med; 1981 Feb; 11(1):193-6. PubMed ID: 7208743 [TBL] [Abstract][Full Text] [Related]
35. Vasopressin function in depression and mania [proceedings]. Gold PW; Goodwin FK; Post RM; Robertson GL Psychopharmacol Bull; 1981 Jan; 17(1):7-9. PubMed ID: 7232662 [No Abstract] [Full Text] [Related]
36. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients. Kolivakis T; Azim H; Kingstone E Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674 [No Abstract] [Full Text] [Related]
37. A comparison of thiothixene with chlorpromazine in the treatment of mania. Janicak PG; Bresnahan DB; Sharma R; Davis JM; Comaty JE; Malinick C J Clin Psychopharmacol; 1988 Feb; 8(1):33-7. PubMed ID: 3280617 [TBL] [Abstract][Full Text] [Related]
38. Manic depression: an overview. Dixson DL J Psychiatr Nurs Ment Health Serv; 1981 Jun; 19(6):28-31. PubMed ID: 6265629 [No Abstract] [Full Text] [Related]
39. Gestational mania. Kubacki A Can J Psychiatry; 1980 Oct; 25(6):525-7. PubMed ID: 7417929 [No Abstract] [Full Text] [Related]
40. Molecular mechanisms in the actions of drugs active in mania and depression. A symposium: Collegium Internationale Neuropsychopharmacologicum (C.I.N.P.) Congress, Jerusalem, Israel, 20-25 June 1982. Neuropharmacology; 1983 Mar; 22(3 Spec No):359-446. PubMed ID: 6856047 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]